89Zr-girentuximab
telix pharmaceuticals
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
an important study from for imaging targeting ca-ix, receptor generally positive for clear cell #kidneycancer. will change how we evaluate and decide on biopsy. #gu23 
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: https://t.co/Whk29PATXe